Processing

(Image: Getty/Monsitj)

Five stories that speak volumes about US generics market

By Ben Hargreaves

As Novartis looks to sell a major chunk of its generics portfolio in the US, in-PharmaTechnologist has a look back at some of the stories this year that have signposted larger, on-going trends in the US generics market.